江湖电竞赛事直播决赛
¥ 33.77
Previous Close |
---|
¥32.76 |
Overview
688278 Overview
Key Data
- Open ¥32.60
- Day Range 32.33 - 33.93
- 52 Week Range 21.32 - 36.15
- Market Cap ¥13.33B
- Shares Outstanding 406.8M
- Public Float 138.74M
- Beta N/A
- Rev. per Employee ¥1.087M
- P/E Ratio 56.59
- EPS ¥0.60
- Yield 0.30%
- Dividend ¥0.10
- Ex-Dividend Date May 24, 2022
- Short Interest N/A
- % of Float Shorted N/A
- Average Volume 2.42M
Performance
5 Day |
|
1 Month |
|
3 Month |
|
YTD |
|
1 Year |
|
Xiamen Amoytop Biotech Co. Ltd. A
Xiamen Amoytop Biotech Co. Ltd. engages in the research and development of genetic engineering technology. It develops recombinant protein drugs such as rHuGM-CSF, rHuG-CSF, rHuIL-11, rHuIFN a-2a and rHuIFN a-2b.The company's products include Molgramostim, Filgrastim, and Oprelvekin. Xiamen Amoytop Biotech was founded on August 7, 1996 and is and is headquartered in Xiamen, China.